ATS View
한국어

Bukwang Pharmaceutical IND KRX:003000KOSPI

부광약품 · Korean news coverage and regulatory filings, organized.

한국어
Articles, 24h23
Articles, 7 days34
DART filings, 7 days0
Articles tracked166since Sep 11

In Q2 2026, Bukwang Pharmaceutical IND reported revenue of ₩57.0bn, up 33.8% year on year, and operating profit of ₩1.4bn. Bukwang Pharmaceutical IND (부광약품) appeared in 34 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Oct 23 with 51 articles. The most common catalyst was earnings (22). It was most often mentioned alongside 글로벌테크놀로지, Woori Financial Group and Hana Financial Group.

Filing signals Revenue +30% Screener

Bukwang Pharmaceutical IND quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩57.0bn+33.8%₩1.4bn
margin 2.5%		₩1.4bn
Q1 2026₩47.8bn-0.1%₩1.1bn
margin 2.3%		₩1.2bn
Q4 2025 derived₩62.5bn+35.4%₩8.2bn
margin 13.0%		₩4.7bn
Q3 2025₩47.8bn+12.2%₩979m
margin 2.0%		₩1.5bn
Q2 2025₩42.6bn+15.3%₩2.0bn
margin 4.7%		₩6.4bn
Q1 2025₩47.8bn+39.0%₩3.0bn
margin 6.3%		−₩111m
Q4 2024 derived₩46.2bn+84.6%₩2.0bn
margin 4.2%		₩1.8bn
Q3 2024₩42.6bn+110.3%₩3.2bn
margin 7.5%		₩99m

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Bukwang Pharmaceutical IND top stories 2 weeks, by number of outlets

  1. 1
    부광약품, 조현병 디지털 치료제 ‘어펙터스’ 공동개발 참여
    16 outlets · 16 articlesFirst report Oct 22 08:36 메디포뉴스Partnership
  2. 2
    부광약품, 창립 66주년 맞아 기업 CI 개편
    6 outlets · 6 articlesFirst report Oct 30 08:04 메디파나뉴스
  3. 3
    부광약품, 3분기 영업이익 21억6100만원…전년 동기 대비 120.7% 증가
    5 outlets · 5 articlesFirst report Oct 23 09:20 CBC뉴스Earnings
  4. 4
    부광약품, CI 리뉴얼…새 슬로건 공개
    4 outlets · 4 articlesFirst report Oct 30 08:08 메디포뉴스
  5. 5
    부광약품, 창립 66년 맞아 CI 새 단장…"신뢰 위에 혁신을 열다"
    4 outlets · 4 articlesFirst report Oct 30 08:27 메디파나뉴스
  6. 6
    부광약품, 3분기 영업익 120% 증가 … 누적 기준 22.2% 감소
    3 outlets · 4 articlesFirst report Oct 23 10:14 뉴데일리경제Earnings

Latest Bukwang Pharmaceutical IND news Korean headlines